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Electroconvulsive therapy mediates neuroplasticity of white
matter microstructure in major depression
H Lyden1, RT Espinoza2, T Pirnia1, K Clark3, SH Joshi1, AM Leaver1, RP Woods1,2 and KL Narr1,2
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depressive disorder (MDD) remains
uncertain. We examined diffusion tensor imaging (DTI) correlates of WM structural connectivity in patients receiving
electroconvulsive therapy (ECT), a rapidly acting treatment for severe MDD. Tract-Based Spatial Statistics (TBSS) applied to DTI data
(61 directions, 2.5 mm3 voxel size) targeted voxel-level changes in fractional anisotropy (FA), and radial (RD), axial (AD) and mean
diffusivity (MD) in major WM pathways in MDD patients (n= 20, mean age: 41.15 years, 10.32 s.d.) scanned before ECT, after their
second ECT and at transition to maintenance therapy. Comparisons made at baseline with demographically similar controls (n= 28,
mean age: 39.42 years, 12.20 s.d.) established effects of diagnosis. Controls were imaged twice to estimate scanning-related
variance. Patients showed significant increases of FA in dorsal fronto-limbic circuits encompassing the anterior cingulum, forceps
minor and left superior longitudinal fasciculus between baseline and transition to maintenance therapy (Po0.05, corrected).
Decreases in RD and MD were observed in overlapping regions and the anterior thalamic radiation (Po0.05, corrected). Changes in
DTI metrics associated with therapeutic response in tracts showing significant ECT effects differed between patients and controls.
All measures remained stable across time in controls. Altered WM microstructure in pathways connecting frontal and limbic areas
occur in MDD, are modulated by ECT and relate to therapeutic response. Increased FA together with decreased MD and RD, which
trend towards normative values with treatment, suggest increased fiber integrity in dorsal fronto-limbic pathways involved in mood
regulation.
Translational Psychiatry (2014) 4, e380; doi:10.1038/tp.2014.21; published online 8 April 2014
INTRODUCTION
Despite the availability of effective treatments for major depres-
sive disorder (MDD), only half to two-thirds of patients can expect
to achieve remission.1–4 Understanding the mechanisms of
treatment response is thus a priority for improving health
outcomes. Available evidence supports that brain networks
involved in mood, vegetative states and cognition contribute to
MDD. Neuroimaging research points to structural and functional
abnormalities in components of these networks, which include the
anterior cingulate (ACC), dorsolateral (DLPFC), dorsomedial
(DMPFC) and ventral prefrontal cortex (VPFC) and hippocampal,
amygdalar, thalamic and striatal subcortical centers.5–7 Altered
connectivity between network components is also shown to
associate with MDD.7–9 As white matter (WM) architecture
accounts for structural connectivity, and the strength and
persistence of functional connectivity is shown to reflect and be
constrained by structural connectivity,10,11 microstructural proper-
ties of WM may have an important role in the pathophysiology of
MDD and in treatment response.
A growing number of cross-sectional studies have used
diffusion tensor imaging (DTI) to investigate WM microstructure
in MDD. Despite different methodological approaches, most
investigations report MDD-related reductions of fractional aniso-
tropy (FA), used as an index of WM integrity. For example, a
systematic review, though focusing more broadly on affective
disorders, reported smaller FA in patients relative to controls in 21
of 27 studies, where abnormalities in frontal and temporal regions
were most reproducible.12 A meta-analysis including seven studies
of MDD showed smaller FA in the superior longitudinal fasciculus
(SLF),13 an association pathway connecting frontal, temporal and
parietal regions.14 A more recent meta-analysis including 11 DTI
studies (four overlapping with the prior meta-analysis) pointed to
smaller FA in frontal lobe WM, as well as in right fusiform and
occipital lobe WM in MDD.9 Altered FA in the sagittal striatum,15
which includes intersecting fibers from the SLF, and the inferior
longitudinal (ILF) and fronto-occipital fasciculi (IFO),16–20 the
internal and external capsule,16,19,21,22 cingulate/
cingulum15,21,23–25 and other frontal association pathways18,24–26
are further reported in independent studies of MDD. Thus, though
frontal, limbic and striatal connections are implicated, the regional
pattern of altered WM structural connectivity in MDD requires
clarification. Targeting changes in WM microstructure in associa-
tion with treatment may help determine which WM pathways are
most relevant to disease processes as well as indicate how
neuroplasticity in structural networks relates to therapeutic
response.
Previous reports show that WM abnormalities relate to illness
severity and are pronounced in treatment-resistant
depression.17,27–30 However, longitudinal studies delineating the
correlates and predictors of treatment response are few. One
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group using a whole brain voxel-based analysis approach not
restricted to WM, showed treatment-related increases of FA in the
left medial superior frontal cortex and decreased FA in the angular
gyrus in 21 MDD patients after four weeks of guided image
psychotherapy.31 Another group employing similar methods
showed significant increases in FA in clusters in the left frontal
gyrus in 17 MDD patients undergoing a 4-week trial of repetitive
transcranial magnetic stimulation, but not in patients receiving
sham stimulation.32 Electroconvulsive therapy (ECT), another brain
stimulation technique used to treat treatment-resistant depression
that elicits a more rapid and definitive response,33 provides a
valuable model to examine treatment effects over relatively short
intervals. One early study in patients with late-life MDD (n= 8)34
showed increased FA post-ECT in WM sampled discretely from
specific regions of interest (ROIs) in the frontal and temporal lobes.
To better determine the neurobiological effects of rapid
treatment response, we used DTI to assess changes in WM
microstructure in 20 patients with MDD followed prospectively
while receiving ECT. Comparing patients with 28 controls at
baseline established effects of diagnosis. Analyses employed FSL’s
TBSS (Tract Based Spatial Statistics),35 allowing for the investiga-
tion of implicated tracts as well as for the unbiased exploration of
other WM changes at the voxel level. Variations in FA as well as in
radial (RD), axial (AD) and mean diffusivity (MD), which may point
to particular properties of fiber integrity and coherence, were
included as dependent measures. Associations with clinical
response were examined in tracts showing significant treatment
effects. Since neural models of MDD support a dysregulation
between under reactive dorsal (DLPFC and DMPFC and dorsal
ACC) and over active ventral (orbitofrontal, subgenual ACC,
amygdala) fronto-limbic circuitry,36–39 we hypothesized that
treatment-related changes in structural connectivity would occur
in dorsal and ventral pathways involved in mood regulation and
emotion.
MATERIALS AND METHODS
Participants
Patients were recruited from individuals independently scheduled to
receive ECT as part of their routine care at the University of California, Los
Angeles (UCLA) Resnick Neuropsychiatric Hospital. Eligibility required
patients to have recurrent MDD and a DSM-IV TR diagnosis of a major
depressive episode as confirmed by psychiatric evaluation and the Mini-
International Neuropsychiatric Interview (M.I.N.I.).40 Patients with comorbid
psychiatric disorders or dementia were excluded. Additional exclusionary
criteria included first episode depression, onset after 50 years, depression
related to a serious medical illness, and ECT or other neuromodulation
treatments (vagal nerve stimulation, repetitive transcranial magnetic
stimulation) within 6 months of current index ECT series. All patients
were tapered off medications including antidepressants, benzodiazepines
and anticonvulsants for at least 48 to 72 h before enrolling in this study
and receiving treatment.
ECT was administered using the ST (seizure threshold) titration method;
individual STs were determined using established stimulus dosing
techniques. Sixteen patients received right unilateral d’Elia lead placement
and four patients received right unilateral as well as bilateral bitemporal
lead placement during their index series. After seizure threshold was
determined at the first ECT session, subsequent treatments were delivered
at energy settings 5x ST for right unilateral ECT and at 1.5x ST for
bilateral ECT.
Demographically similar control subjects were recruited from the Los
Angeles area using flyers. Controls received M.I.N.I. screening40 and were
excluded if they had a history of depression or any other psychiatric illness,
and/or history of antidepressant use. Exclusion criteria for all subjects
included history of alcohol or substance abuse within the past 6 months
and/or dependence within the past 12 months, any neurological disorder,
and any condition that would contraindicate MRI scanning.
Patients with MDD (n= 20) received scanning and mood evaluations at
three separate time points: (1) within 24 h before their first ECT session
(baseline), (2) after the second ECT session occurring ~ 48 h after their first
ECT session (time point 2) and (3) within 1 week of completion of their ECT
index series (time point 3), at which time they transitioned to a
maintenance therapy (range of ECT index: 9–19 ECT sessions as
individually determined). Mood scales collected at each time point
included the Hamilton Rating Scale for Depression (HAM-D, 17-item),41
the Montgomery-Åsberg Depression Rating Scale (MADRS)42 and the Quick
Inventory of Depressive Symptomology Self-Report (QIDS-SR,16-item).43
To estimate the variance associated with serial scanning and to establish
normative values, control subjects (n=28) were scanned twice at intervals
similar to patient baseline and transition scans. Demographic and clinical
information for all subjects is provided in Table 1. All participants provided
written informed consent and the study was approved by the UCLA
Institutional Review Board.
Image acquisition and processing
DTI data were acquired on a Siemens 3T Allegra MRI system with an RF
transmit/receive head coil using a spin-echo, echo-planar sequence
including 61 non-collinear, icosahedrally distributed directions, 10 b0
Table 1. Subject demographics and means and standard deviations for DTI metrics by group and time point
Patients with MDD (n= 20) Controls (n= 28)
Age, years: mean (s.d.) 41.15 (10.32) 39.42 (12.12)
Male/female 8/12 13/15
Education, years: mean (s.d.) 10.47 (2.81) 11.39 (2.01)
Left handersa 6 (30%) 4 (14%)
Age of onset, years: mean (s.d.)b 19.86 (11.17) —
Duration of illness, years: mean (s.d.)b 21.62 (12.51) —
Baseline Time 2 Time 3 Baseline Time 2
HAM-D 27.42 (4.50) 21.26 (6.87) 11.68 (7.65) — —
MADRS 42.21 (7.13) 33.36 (10.51) 15.26 (10.24) — —
QIDS 21.73 (3.57) 17.21 (5.22) 8.78 (5.266) — —
FA: mean (s.d.)c 0.502 (0.031) 0.509 (0.029) 0.519 (0.030) 0.521 (0.023) 0.521 (0.026)
MD: mean (s.d.)c 6.23 (0.23) 6.15 (0.24) 6.02 (0.23) 6.06 (0.18) 6.02 (0.02)
RD: mean (s.d.)c 3.90 (0.31) 3.82 (0.31) 3.70 (0.31) 3.70 (0.24) 0.368 (0.31)
Abbreviations: DTI, diffusion tensor imaging; FA, fractional anisotropy; HAM-D, Hamilton Rating Scale for Depression; MADRS, Montgomery-Åsberg Depression
Rating Scale; MD, mean diffusivity; MDD, major depressive disorder; QIDS, Quick Inventory of Depressive Symptomology; RD, radial diffusivity. aHandedness
was estimated using the modified Edinburgh Handedness Inventory44 where a laterality quotient of o0.7 was used to define left-handers or non-dextral
subjects. bAge of onset and duration of illness was unavailable for four subjects. cFA, MD and RD values are averaged from within tract-specific regions of
interest showing significant overall effects of electroconvulsive therapy. MD and RD values have been multiplied by 10 000.
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images and 55 axial slices (TR/TE: 7300/95ms, b = 0, 1000 s/ mm2; FOV:
24 cm, 96× 96 matrix, 2.5 mm isotropic voxel size). For processing, images
were corrected for slice prescription and for residual eddy current
distortions and motion artifacts using combined nonlinear 2-dimensional
and 3-dimensional rigid body registrations.45,46 The diffusion tensor was
computed at each voxel using a linear least squares method.47 The
resultant eigen values were used to compute FA (degree of anisotropic
diffusion), AD (λ1, diffusivity along the principal axis), RD ((λ2+λ3)/2),
diffusivity along the two minor axes) and MD (overall diffusivity).
Preprocessing was performed using in-house software written in C.48,49
FA, AD, RD and MD images were scalp-edited using masks generated from
the co-registered b0 images.50
Voxel-wise statistical analysis used validated TBSS workflows,35 which
form part of FSL.50 In brief, FA images were first aligned within and across
subjects and then to standard MNI152 space using combined nonlinear
and affine registrations. A mean FA image (FA threshold: 0.2) was
subsequently created and thinned to represent a FA skeleton common to
all subjects and time points. The aligned FA data from each subject or time
Figure 1. Significant longitudinal effects of ECT and cross-sectional effects of diagnosis from voxel-based and ROI analysis. Left: significant
increases in FA (top) shown in red, and decreases in MD (middle) and RD (bottom) shown in blue from voxel-based analyses comparing
baseline and the end of the ECT index series (time point 3; Po0.05, corrected). Significant effects are superimposed onto the MNI 152 atlas,
with the FA white matter skeleton for all subjects shown in green. Right: mean FA (top), mean MD (middle) and mean RD (bottom) averaged
within regions showing significant ECT effects plotted by group and time point. The bold asterisks indicate significance between baseline and
time point 3 corresponding to the TBSS analysis for each DTI metric shown on the right. Smaller asterisks indicate significance between
groups or time point for tract-specific ROIs compared in follow-up analysis. DTI, diffusion tensor imaging; ECT, electroconvulsive therapy; FA,
fractional anisotropy; MD, mean diffusivity; RD, radial diffusivity; ROI, region of interest.
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point was then projected onto this skeleton to allow voxel-wise
comparisons within major WM pathways. The transformation files and
skeleton projection vectors generated for the FA images were applied to
the MD, RD and AD images to allow comparison of these diffusion metrics
in the same common space.
Statistical analysis
FSL’s Randomise tool (http://www.fmrib.ox.ac.uk/fsl/randomise/index.
html), which combines the general linear model (GLM) with permutation
testing, was used for voxel-based analysis of each diffusion metric. Paired t-
tests established longitudinal changes in patients scanned at three time
points, with each of the time points compared pairwise, and in controls
scanned at two time points. Cross-sectional comparisons between patients
at baseline and controls (using the first time point only) controlled for age
and gender. FSL’s threshold-free cluster enhancement (TFCE) methods
corrected for multiple statistical testing using 5000 randomly generated
permutations and a threshold t>2, Po0.05. The anatomical locations of
clusters showing significant effects were identified using the Johns
Hopkins University (JHU) DTI-based WM atlas.51
In follow-up analyses, FA, AD, RD or MD values were also averaged,
plotted and compared within WM ROIs showing significant longitudinal
effects of ECT. The same ROIs were used to compare differences between
patients and controls and to examine associations with clinical response.
Associations with therapeutic response were assessed using the general
linear mixed model (GLMM) including HAM-D, MADRS or QIDS ratings as
covariates of interest, time point as a repeated measure and subject as a
random factor. Finally, to determine whether baseline measures may
predict subsequent clinical response, correlations between baseline DTI
measures and change in clinical scores between baseline and time point 3
were examined.
RESULTS
Subject characteristics
Patient and control groups did not differ significantly in age F
(1,47) = 0.13, P= 0.71, gender Χ2(1,47) = 0.96, P= 0.65 or education
F(1,47) = 1.89, P= 0.17.
Longitudinal effects
HAM-D, MADRS and QIDS scores improved between baseline and
time point 2, t(1,19) = 4.33, 5.25 and 5.75, respectively, all
Po0.001; time point 2 and 3, t(1,19) = 3.90, 4.78 and 5.42, all
Po0.001; and baseline and time point 3, t(1,19) = 6.30; 6.91 and
7.92, all Po0.0001.
Patients showed significant increases in FA between baseline
and time point 3 in the bilateral anterior cingulum, forceps minor,
and the left SLF (Po0.05, corrected; Figure 1, top left). Though
comparisons with time point 2 remained below the threshold of
significance in voxel-level analysis, when averaged in tract ROIs
showing significant overall effects of ECT (baseline versus the end
of the ECT index), FA was shown as significantly increased
between the second and third time points, t(1,19) = 2.81, Po0.01
(Figure 1, top right).
Patients showed decreases in MD in the left anterior cingulum,
left forceps minor and left anterior thalamic radiation (ATR)
between baseline and time point 3 (Po0.05, corrected; Figure 1,
middle left). MD averaged within ROIs showing significant overall
effects of ECT, were again shown to vary between the second and
third time points, t(1,19) =− 2.51, P= 0.02 (Figure 1, middle right).
Decreases in RD were observed in the same regions showing FA
effects (forceps minor, anterior cingulum, and left SLF) between
baseline and time point 3 (Po0.05, corrected; Figure 1, bottom
left). RD in ROIs showing significant overall effects of ECT also
differed between the second and third time points, t(1,19) = 2.62,
P= 0.017 (Figure 1, bottom right). Means for FA, MD and RD from
ROIs showing significant ECT effects are provided in Table 1.
Longitudinal effects were absent for AD. Significant differences
between baseline and follow-up scanning were absent for all DTI
metrics in controls. In Supplementary Figures 1–3, longitudinal
effects of ECT are mapped after separating each tract exhibiting
significant effects.
Cross-sectional effects
Though differences between diagnostic groups at baseline were
not detected after correction for multiple comparisons at the
voxel level, follow-up analyses revealed appreciable diagnostic
group effects in the same tract ROIs showing significant
longitudinal changes of ECT. Specifically, patients showed
significantly smaller FA values in the cingulum, forceps minor,
and left SLF compared with controls, F(1,47) = 5.00, P= 0.03
(Figure 1, top right). Larger MD values (Figure 1, middle right)
and RD values (Figure 1, bottom right) were observed in
overlapping regions, F(1,47) = 6.07, P= 0.018 and F(1,47) = 4.34,
Po0.043, respectively. No differences between diagnostic groups
were observed when DTI measures were compared between
controls and patients assessed at the second or third time points,
all P>0.14.
Associations with clinical scores
Treatment-related increases in FA associated with decreased
MADRS, F(1,20.90) = 12.41, Po0.002; HAM-D, F(1,20.98) = 13.41,
Po0.001 and QIDS, F(1,21.24) = 16.85, Po0.0001, ratings
(Figure 2, top). Decreases in MD associated with decreased
MADRS, F(1,20.35) = 18.93, Po0.0001; HAM-D, F(1,20.68) = 22.09,
P= 0.0001 and QIDS, F(1,21.49) = 24.81, P= 0.0001, scores (Figure 2,
middle). Likewise, decreases in RD associated with decreased
MADRS, F(1,20.89) = 12.42, Po0.002; HAM-D, F(1,21.01) = 14.19,
P= 0.001 and QIDS, F(1,21.51) = 17.63, P= 0.0001, ratings (Figure 2,
bottom). DTI measures at baseline, however, were not shown to
significantly associate with the extent of change in mood scales
between baseline and the end of ECT index (all P>0.05).
DISCUSSION
The present study sought to address whether longitudinal
changes in WM microstructure, examined in major tracts
throughout the brain, occur in association with ECT and
treatment-related clinical response. Cross-sectional differences
between diagnostic groups addressed the presence of disease
effects. Several key findings emerged from this investigation. In
patients followed longitudinally, increases in FA and decreases in
RD were shown in the anterior cingulum, the forceps minor and
the dorsal aspect of the left SLF between baseline and the end of
the ECT index series. Decreases in MD occurred in overlapping
regions and in the anterior thalamic radiation, though were more
left lateralized. Longitudinal changes within these pathways,
which maintain more dorsal fronto-limbic connections, were
associated with improved clinical response. In cross-sectional
analysis, FA, MD and RD, measured in the same tract-specific ROIs
exhibiting overall effects of ECT, were shown to differ between
patients and controls at baseline. All DTI metrics remained stable
over time in controls, and were not shown to vary between
diagnostic groups once patients had initiated ECT, suggesting that
ECT acts to normalize MDD-related abnormalities in the structural
connectivity of dorsal fronto-limbic pathways.
Though reductions of FA are typically reported in prior cross-
sectional DTI investigations of MDD, results remain mixed at the
regional level.9,12,13 As apparent from two meta-analytic
studies,9,13 the examination of relatively small (median: n= 21;
range: 15–52) and clinically and demographically heterogeneous
samples may contribute to discrepancies in results. The use of
larger voxel sizes, fewer gradient directions, voxel-based analysis
methods sensitive to registration confounds or approaches that
are limited to assessing arbitrarily selected regions that may not
focus on WM exclusively may also account for mixed findings. The
current study attempted to minimize some of these prior
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limitations by using higher angular resolution data and analysis
methods more robust to registration confounds.35 Though
differences between diagnostic groups were not observed at the
voxel-level after correction procedures, significant differences in
FA, MD and RD were observed in the same anatomical regions
showing ECT-related neuroplasticity. By focusing on pathways
showing microstructural changes in association with treatment,
our findings thus indicate that decreases of FA and increases of RD
and MD in pathways linking frontal and limbic structures may
represent a biological marker of MDD.
FA varies in relation to AD and RD. However, the separate
examination of these scalar metrics may better determine the
neurobiological determinates of altered WM microstructure. Prior
work in animals and humans suggest that decreases in AD may
reflect axonal damage52,53 and/or pruning.54 In contrast, increases
in RD may reflect decreased myelination.53,55,56 Larger MD may
indicate myelin breakdown, decreased cellular density or
increased extracellular volumes.57,58 Observations of increased
FA with decreased RD in the current study thus suggest increased
fiber coherence and organization that may relate to processes of
myelination or other properties of fiber membranes. Observations
of treatment-related decreases in MD similarly suggest plasticity
relating to myelination, but may also reflect decreases of
inflammation and/or related changes in cell density or
Figure 2. Relationships between change in clinical ratings and change in FA, MD and RD within regions showing significant ECT effects. The Y
axis shows mean FA (top), mean MD (middle) and mean RD (bottom) values from tract-specific ROIs. MADRS, HAM-D and QIDS scores are
shown on the X axis. Values obtained from each patient are mapped in a different color with a data point for each time point (baseline, after
the second ECT session and at the end of the ECT index series). Subject-specific regression lines indicate relationships between FA, MD and RD
and MADRS, HAM-D and QIDS ratings across time. These relationships were significant for all DTI metrics (all Po0.001). DTI, diffusion tensor
imaging; ECT, electroconvulsive therapy; FA, fractional anisotropy; HAM-D, Hamilton Rating Scale for Depression; MADRS, Montgomery–-
Åsberg Depression Rating Scale; MD, mean diffusivity; QIDS, Quick Inventory of Depressive Symptomology; RD, radial diffusivity; ROI, region of
interest.
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extracellular volume. Though limitations of the tensor model may
lead to a misattribution of biophysical properties in regions with
crossing fibers,59 this potential confound is less likely to impact
the current findings given that effects were observed in clusters
extending across several major WM tracts.
Though very few DTI studies have assessed treatment effects in
MDD, our results are compatible with one prior study showing
increased FA in preselected frontal regions pre-to-post ECT in a
preliminary investigation of late-life depression.34 Our results
further demonstrate ECT-related changes in the structural
connectivity of selected fronto-limbic pathways.60 Findings from
functional and electrophysiological imaging have shown hypo-
metabolism, decreased blood flow or activity in the dorsal ACC
and hyperactivity or increased blood flow in more ventral limbic
structures in MDD.39,61–63 Several treatment studies have also
shown that ACC activity relates to and may predict treatment
response.64–67 These prior observations support models of MDD
indicating a dysregulation between under reactive dorsal (DLPFC
and DMPFC and dorsal ACC) and overactive ventral (orbitofrontal,
subgenual ACC, amygdala) fronto-limbic circuitry with mediation
by the thalamus and striatum.36–39 This pattern of altered
functional circuitry can be interpreted to reflect a dissociation
between dorsal regions with preferential involvement in emo-
tional regulation from ventral regions with primary involvement in
emotion generation.36
The ACC is linked to both emotional processing as well as to
pain circuitry.68,69 With its connections to frontal and limbic
system substructures, including the amygdala, hippocampus and
insula, the ACC is involved in avoidance learning, affective pain,
emotional recall and salience monitoring (for negative stimuli in
particular) and emotional processing modulated by cognitive
activity.37,68–70 The forceps minor, which contains axonal projec-
tions to the lateral and medial prefrontal cortex through the
anterior callosum, also forms part of fronto-limbic circuitry and
may therefore assist in regulating depressive symptoms.39,63
Treatment-related changes in WM microstructure observed in
the dorsal anterior cingulum, forceps minor and superior SLF
(situated above the ACC and connecting parietal cortex, DLPFC
and DMPFC14), and frontally projecting thalamic fibers, suggest
plasticity in neural circuits most compatible with the dorsal
network. Thus, treatment-related plasticity may be more closely
related to improvements in control over emotional states to
regulate mood.63 However, both direct and indirect bi-directional
anatomical connections exist between nodes of dorsal and ventral
networks, emphasizing interactions and overlaps between these
systems.36,37
Though structural connectivity does not completely equate
with functional connectivity, the present findings are also
compatible with recent studies addressing altered functional
connectivity in MDD, which point to dysregulation within default
mode, affective and/or cognitive control networks that include the
ACC, DLPFC, VPFC, DMPFC, limbic substructures and
thalamus.71–73 Although few studies have addressed links
between resting state functional connectivity and antidepressant
response, a recent investigation of nine patients with MDD, who
remained on psychotropic medications, showed decreased
activity in the left DLPFC and correlated activity in the right
DLPFC, DMPFC, ACC and left parietal and somatosensory cortex
following ECT treatment (mean number of ECT sessions: 8.3)74 and
relationships with clinical response. Though our findings of
structural connectivity using DTI imply that ECT associates with
increased rather than decreased connectivity in dorsal fronto-
limbic circuits, WM pathways showing significant treatment
effects maintain both direct and indirect connections with the
functional regions implicated in this prior study.74
Although prior cross-sectional studies remain mixed with regard
to the lateralization of DTI findings, both functional and structural
asymmetries are reported in MDD. As the DLPFC is involved in
cognitive control, findings of leftward effects in DLPFC functional
connectivity74 and our results showing leftward effects in dorsal
fronto-limbic pathways, particularly for MD, may suggest ECT acts
to remediate mood regulation via cognitive control mechanisms
that are more left lateralized. These observations are also
compatible with a body of evidence suggesting depression is
linked with right lateralized hyper-activity and left-lateralized
hypo-activity,75 where ECT may act to modulate this imbalance
through interhemispheric connections of the forceps minor.
However, it is also possible that findings may be influenced by
ECT lead placement as stimulation was targeted to the
nondominant hemisphere in the majority of patients to minimize
potential cognitive side effects. Cell sizes for patients receiving
both unilateral and bilateral lead placement during treatment,
however, were not large enough to examine separately.
Although this is the first study to our knowledge to
demonstrate ECT-related structural plasticity within dorsal
fronto-limbic pathways, some study limitations exist. First,
although longitudinal analyses benefited from more powerful
within-subjects modeling, only ROI analysis revealed significant
diagnostic group effects, which appear more subtle. Second, non-
tensor models applied to diffusion data may better resolve
differences in WM regions with crossing fibers. Tractography
approaches, either deterministic or probabilistic, may also provide
benefits for targeting regional changes in WM structural
connectivity through a priori selected seed regions. Finally, as
the risk of relapse for ECT remains similar to other forms of
antidepressant treatment, investigations following patients for
longer time periods are necessary to determine long-term
predictors of treatment response. In summary, the current study
demonstrates ECT-related plasticity in WM pathways connecting
frontal and limbic regions involved in mood regulation where
increased fiber integrity associates with improved therapeutic
response.
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